Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome

Betatrophin is defined as a new marker in glucose homeostasis and lipid metabolism. We aimed to investigate the role of serum betatrophin in full-blown polycystic ovary syndrome (PCOS) patients and 47-aged healthy women, 51 full-blown PCOS patients were included in this cross-sectional study. Betatr...

Full description

Saved in:
Bibliographic Details
Published in:Gynecological endocrinology 2019-03, Vol.35 (3), p.224-227
Main Authors: Eksi Haydardedeoglu, Filiz, Bagir, Gulay Simsek, Haydardedeoglu, Bulent, Bozkirli, Emre, Bakiner, Okan, Metin, Kerem, Ertorer, Melek Eda
Format: Article
Language:English
Subjects:
Adult
Angiopoietin-like Proteins - blood
betatrophin
Biomarkers - blood
Blood Glucose
Body Mass Index
Cross-Sectional Studies
Female
HOMA-IR
Humans
Insulin - blood
insulin resistance
Insulin Resistance - physiology
Peptide Hormones - blood
Polycystic ovary syndrome
Polycystic Ovary Syndrome - blood
Prospective Studies
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Betatrophin is defined as a new marker in glucose homeostasis and lipid metabolism. We aimed to investigate the role of serum betatrophin in full-blown polycystic ovary syndrome (PCOS) patients and 47-aged healthy women, 51 full-blown PCOS patients were included in this cross-sectional study. Betatrophin concentrations were significantly lower in PCOS group and displayed a positive correlation only with serum tryglyceride in control group (p 
ISSN:0951-3590
1473-0766
DOI:10.1080/09513590.2018.1519791